Kathryn Schmitz, PhD, MPH, and many fellowships: FACSM, FTOS, FNAK, FSBM, FSEM

Kathryn H Schmitz, Ph.D., M.P.H., FACSM, FTOS, FNAK, is a Professor in the division of Hematology and Oncology at the University of Pittsburgh School of Medicine. She serves as the Associate Director of Catchment Area Research, Co-leader of the Biobehavioral Cancer Control program and Director of the Exercise Oncology Initiative for the Hillman Cancer Center. Dr. Schmitz’s research focuses on people living with and beyond cancer and investigates the role of exercise in improving physiologic and psychosocial outcomes, including symptoms, treatment tolerance, and other chronic diseases. In addition, Dr. Schmitz studies technology based supportive care interventions (that include physical activity) to improve outcomes among advanced cancer patients. She has held NCI funding consistently since 2001. She has published over 350 scientific peer reviewed papers, some in prestigious journals such as JAMA, New England Journal of Medicine, and Journal of Clinical Oncology. Her well regarded research on resistance exercise and breast cancer related lymphedema has been translated into a physical therapy delivered program called ‘Strength After Breast Cancer’ that is available in over 1000 locations across the United States and beyond. Dr. Schmitz was the moving force behind two American College of Sports Medicine development processes for exercise and cancer guidelines for patients in 2010 and 2018. She founded the Moving Through Cancer initiative of the American College of Sports Medicine, which has a bold goal of making exercise standard of care in oncology by 2029. She has written a popular press book to raise awareness about exercise for cancer patients and survivors entitled ‘Moving Through Cancer’ that was released by Chronicle Books in October 2021. She is the winner of numerous awards, most notably the Distinguished Scientist Award from the Society of Behavioral Medicine, the Citation Award from the American College of Sports Medicine, and the Clinical Research Professorship from the American Cancer Society. In fall 2023, she was inducted as an Honorary Fellow at the Royal College of Surgeons in Edinburgh, Scotland. She is the past president of the American College of Sports Medicine.